Articles
Volume 14 Supplement 3
Lupus 2012: New targets, new approaches
Meeting abstracts
Lupus 2012: New targets, new approaches
Whistler, Canada
27-30 September 2012
Edited by Peter E Lipsky, John M Esdaile, Matthew H Liang and Paul R Fortin
|
B Richardson Arthritis Research & Therapy 2012, 14(Suppl 3):A1 (27 September 2012) |
|
Follicular helper T Cells and the B cells they help A Poholek, J-Y Choi, S Hernandez, J Weinstein, S Kim, V Bunin, J Odegard, L DiPlacido, J Craft Arthritis Research & Therapy 2012, 14(Suppl 3):A2 (27 September 2012) |
|
M Olferiev, W-T Huang, KA Kirou, E Gkrouzman, D Lundsgaard, KS Frederiksen, J Fleckner, MK Crow Arthritis Research & Therapy 2012, 14(Suppl 3):A3 (27 September 2012) |
|
David Wofsy Arthritis Research & Therapy 2012, 14(Suppl 3):A4 (27 September 2012) |
|
MicroRNA-3148 modulates differential gene expression of the SLE-associated Y Deng, J Zhao, D Sakurai, KM Kaufman, JC Edberg, RP Kimberly, DL Kamen, GS Gilkeson, CO Jacob, RH Scofield, CD Langefeld, JA Kelly, ME Alarcón-Riquelme, BIOLUPUS and GENLES Networks, JB Harley, TJ Vyse, BI Freedman, PM Gaffney, KM Sivils, JA James, TB Niewold, RM Cantor, W Chen, BH Hahn, EE Brown, PROFILE, BP Tsao Arthritis Research & Therapy 2012, 14(Suppl 3):A5 (27 September 2012) |
|
SA Chung, J French, KE Taylor, E Elboudwarej, HL Quach, LF Barcellos, LA Criswell Arthritis Research & Therapy 2012, 14(Suppl 3):A6 (27 September 2012) |
|
CH Feldman, LT Hiraki, J Lui, GS Alarcón, MA Fischer, J Yazdany, KH Costenbader Arthritis Research & Therapy 2012, 14(Suppl 3):A7 (27 September 2012) |
|
SLE risk alleles and cell development and activation SJ Kim, N Manjarrez Orduno, PK Gregersen, B Diamond Arthritis Research & Therapy 2012, 14(Suppl 3):A8 (27 September 2012) |
|
Genetic-epigenetic interaction in lupus AH Sawalha Arthritis Research & Therapy 2012, 14(Suppl 3):A9 (27 September 2012) |
|
H Bilgic, T Koeuth, J Wilson, M Petri, E Baechler Gillespie Arthritis Research & Therapy 2012, 14(Suppl 3):A10 (27 September 2012) |
|
Major congenital anomalies in children born to women with systemic lupus erythematosus E Vinet, CA Pineau, AE Clarke, M Kaouache, C Gordon, R Platt, S Bernatsky Arthritis Research & Therapy 2012, 14(Suppl 3):A11 (27 September 2012) |
|
MM Ward, M Tektonidou Arthritis Research & Therapy 2012, 14(Suppl 3):A12 (27 September 2012) |
|
SS Lim, M Agan, CM Drenkard Arthritis Research & Therapy 2012, 14(Suppl 3):A13 (27 September 2012) |
|
CE Barber, C Barnabe, D Marshall, J Esdaile Arthritis Research & Therapy 2012, 14(Suppl 3):A14 (27 September 2012) |
|
Lung cancer in systemic lupus erythematosus M Kale, R Ramsey-Goldman, S Bernatsky, MB Urowitz, D Gladman, PR Fortin, M Petri, E Yelin, S Manzi, S Edworthy, O Nived, S-C Bae, D Isenberg, A Rahman, JG Hanly, C Gordon, S Jacobsen, E Ginzler, DJ Wallace, GS Alarcón, MA Dooley, L Gottesman, K Steinsson, A Zoma, J-L Senécal, S Barr, G Sturfelt, L Dreyer, L Criswell, J Sibley, JL Lee, AE Clarke et al. Arthritis Research & Therapy 2012, 14(Suppl 3):A15 (27 September 2012) |
|
Lymphoma risk in systemic lupus: effects of treatment versus disease activity AE Clarke, S Bernatsky, KH Costenbader, MB Urowitz, DD Gladman, PR Fortin, M Petri, S Manzi, DA Isenberg, A Rahman, D Wallace, C Gordon, C Peschken, MA Dooley, EM Ginzler, C Aranow, SM Edworthy, O Nived, S Jacobsen, G Ruiz-Irastorza, E Yelin, SG Barr, L Criswell, G Sturfelt, L Dreyer, I Blanco, L Gottesman, CH Feldman, R Ramsey-Goldman Arthritis Research & Therapy 2012, 14(Suppl 3):A16 (27 September 2012) |
|
J Yazdany, C Feldman, J Liu, MM Ward, MA Fischer, KH Costenbader Arthritis Research & Therapy 2012, 14(Suppl 3):A17 (27 September 2012) |
|
Neuropsychiatric events in SLE: determination of attribution and assessment of outcome JG Hanly, Systemic Lupus International Collaborating Clinics Arthritis Research & Therapy 2012, 14(Suppl 3):A18 (27 September 2012) |
|
DL Kamen, MM Peden-Adams, JE Vena, GS Gilkeson, TC Hulsey, L Moultrie, BE Stevens Arthritis Research & Therapy 2012, 14(Suppl 3):A19 (27 September 2012) |
|
CA Peschken, CA Hitchon Arthritis Research & Therapy 2012, 14(Suppl 3):A20 (27 September 2012) |
|
A Lertratanakul, P Wu, A Dyer, W Pearce, G Kondos, D Edmundowicz, J Carr, R Ramsey-Goldman Arthritis Research & Therapy 2012, 14(Suppl 3):A21 (27 September 2012) |
|
MA Mahieu, C Guild, CJ Albert, G Kondos, J Carr, D Edmundowicz, DA Ford, R Ramsey-Goldman Arthritis Research & Therapy 2012, 14(Suppl 3):A22 (27 September 2012) |
|
Differing environmental risk factors for membranous versus proliferative lupus nephritis MA Dooley, CG Parks, GS Cooper Arthritis Research & Therapy 2012, 14(Suppl 3):A23 (27 September 2012) |
|
B cells at the adaptive-innate immune system interface in SLE JH Anolik, A Palanichamy, J Bauer, J Barnard, J Biear, R Dedrick, I Sanz, J Liesveld, E Baechler Arthritis Research & Therapy 2012, 14(Suppl 3):A24 (27 September 2012) |
|
MR Clark, M Giger, Y Jiang, V Liarski Arthritis Research & Therapy 2012, 14(Suppl 3):A25 (27 September 2012) |
|
LL Ritterhouse, HT Maecker, CG Fathman, JT Merrill, JM Guthridge, JA James Arthritis Research & Therapy 2012, 14(Suppl 3):A26 (27 September 2012) |
|
Regulatory natural autoantibodies suppress inflammation and SLE disease activity GJ Silverman, J Vas, C Grönwall Arthritis Research & Therapy 2012, 14(Suppl 3):A27 (27 September 2012) |
|
N Talaei, C Landolt-Marticorena, B Noamani, E Pau, N-H Chang, JE Wither Arthritis Research & Therapy 2012, 14(Suppl 3):A28 (27 September 2012) |
|
Arthritis Research & Therapy 2012, 14(Suppl 3):A29 (27 September 2012) |
|
Dysregulation of the serine/threonine phosphatase PP2A contributes to autoimmunity JC Crispín Arthritis Research & Therapy 2012, 14(Suppl 3):A30 (27 September 2012) |
|
PL Cohen, B Hilliard, W-H Shao Arthritis Research & Therapy 2012, 14(Suppl 3):A31 (27 September 2012) |
|
BJ Barnes, RC Stone, P Du, D Feng Arthritis Research & Therapy 2012, 14(Suppl 3):A32 (27 September 2012) |
|
R Bucala Arthritis Research & Therapy 2012, 14(Suppl 3):A33 (27 September 2012) |
|
Interplay of neutrophils and type I interferons in the development of end-organ damage in SLE MJ Kaplan Arthritis Research & Therapy 2012, 14(Suppl 3):A34 (27 September 2012) |
|
A Perl Arthritis Research & Therapy 2012, 14(Suppl 3):A35 (27 September 2012) |
|
Microparticles as autoantigens in human and murine lupus A Ullal, DS Pisetsky Arthritis Research & Therapy 2012, 14(Suppl 3):A36 (27 September 2012) |
|
Innate sensors for nucleic acids and lupus pathogenesis AN Theofilopoulos, R Gonzalez-Quintial, Y-T Koh, R Baccala, DH Kono Arthritis Research & Therapy 2012, 14(Suppl 3):A37 (27 September 2012) |
|
Evaluating the B-cell C3d:CR2 innate-adaptive immune interaction as a therapeutic target in lupus VM Holers, JM Thurman, JP Hannan, L Kulik Arthritis Research & Therapy 2012, 14(Suppl 3):A38 (27 September 2012) |
|
PROMISSE: progress in understanding pregnancy complications in patients with SLE JE Salmon Arthritis Research & Therapy 2012, 14(Suppl 3):A39 (27 September 2012) |
|
Complement deficiencies and susceptibility to systemic lupus erythematosus revisited KB Elkon, DM Santer, A Wiedeman Arthritis Research & Therapy 2012, 14(Suppl 3):A40 (27 September 2012) |
|
JP Buyon Arthritis Research & Therapy 2012, 14(Suppl 3):A41 (27 September 2012) |
|
MicroRNAs in innate immune responses and autoimmune diseases EKL Chan Arthritis Research & Therapy 2012, 14(Suppl 3):A42 (27 September 2012) |
|
M Ghoreishi, L Tucker, JP Dutz Arthritis Research & Therapy 2012, 14(Suppl 3):A43 (27 September 2012) |
|
SLE: insights from array-based proteomics T Wu, Y Du, L Davis, C Mohan Arthritis Research & Therapy 2012, 14(Suppl 3):A44 (27 September 2012) |
|
S Parikh, A McKinley, BH Rovin Arthritis Research & Therapy 2012, 14(Suppl 3):A45 (27 September 2012) |
|
Cytokine profiles of lupus patients with or without nephritis BH Rovin, H Song, CL Hines, X Zhang Arthritis Research & Therapy 2012, 14(Suppl 3):A46 (27 September 2012) |
|
Which lupus trial endpoints best reflect clinical judgment or biomarker improvement? A Thanou, M Munroe, S Kamp, F Carthen, JA James, JT Merrill Arthritis Research & Therapy 2012, 14(Suppl 3):A47 (27 September 2012) |
|
EC Somers, W Marder, P Cagnoli, EE Lewis, P DeGuire, C Gordon, CG Helmick, L Wang, JJ Wing, JP Dhar, J Liesen, WJ McCune, MiLES Group Arthritis Research & Therapy 2012, 14(Suppl 3):A48 (27 September 2012) |
|
J Cabas-Vargas, NM Patel, J Cohen, EM Ginzler Arthritis Research & Therapy 2012, 14(Suppl 3):A49 (27 September 2012) |
|
M McMahon, Lori Sahakian, J Grossman, B Skaggs, J Fitzgerald, C Charles-Schoeman, N Ragavendra, A Gorn, G Karpouzas, M Weisman, D Wallace, B Hahn Arthritis Research & Therapy 2012, 14(Suppl 3):A50 (27 September 2012) |
|
Thinking toward improved treatments of systemic lupus erythematosus BH Hahn, J Grossman, B Skaggs, E Lourenco, M Wong Arthritis Research & Therapy 2012, 14(Suppl 3):A51 (27 September 2012) |
|
Hopkins Lupus Cohort: assessment of treatment effects M Petri Arthritis Research & Therapy 2012, 14(Suppl 3):A52 (27 September 2012) |
|
JA Aviña-Zubieta, D Lacaille, EC Sayre, J Kopec, HK Choi, JM Esdaile Arthritis Research & Therapy 2012, 14(Suppl 3):A53 (27 September 2012) |
|
Poor methodological reporting in lupus clinical trials found in Cochrane reviews CH Goldsmith Arthritis Research & Therapy 2012, 14(Suppl 3):A54 (27 September 2012) |
|
Z Touma, DD Gladman, MB Urowitz Arthritis Research & Therapy 2012, 14(Suppl 3):A55 (27 September 2012) |
|
D Rigdon, AC Gotte, MG Punaro, TB Wright Arthritis Research & Therapy 2012, 14(Suppl 3):A56 (27 September 2012) |
|
Role of anti-Ro autoantibodies in systemic lupus erythematosus patients with recurrent myositis S Umer, S Hayat, G Caldito, SM Berney Arthritis Research & Therapy 2012, 14(Suppl 3):A57 (27 September 2012) |
|
LT Hiraki, CH Feldman, J Liu, GS Alarcón, MA Fischer, WC Winkelmayer, KH Costenbader Arthritis Research & Therapy 2012, 14(Suppl 3):A58 (27 September 2012) |
|
Hospitalizations in patients with systemic lupus erythematosus: updated analyses from 2006 to 2011 K Chan, A Dekis, AE Clarke, CA Pineau, E Vinet, E Nashi, S Bernatsky Arthritis Research & Therapy 2012, 14(Suppl 3):A59 (27 September 2012) |
|
B-cell receptor signaling studies in patients with lupus: preliminary results M Faludi, A Mao, E Vinet, A Clarke, C Pineau, S Bernatsky, E Nashi Arthritis Research & Therapy 2012, 14(Suppl 3):A60 (27 September 2012) |
|
Lupus cardiomyopathy: a reversible form of left ventricular dysfunction ML Ishimori, M Agarwal, RK Ng, LD Nugent, DJ Wallace, RJ Siegel, MH Weisman Arthritis Research & Therapy 2012, 14(Suppl 3):A61 (27 September 2012) |
|
Prevalence of angina in patients with systemic lupus erythematosus ML Ishimori, NJ Gal, A Rogatko, DS Berman, A Wilson, DJ Wallace, NB Merz, MH Weisman Arthritis Research & Therapy 2012, 14(Suppl 3):A62 (27 September 2012) |
|
MA Jensen, KC Patterson, AA Kumar, M Kumabe, BS Franek, TB Niewold Arthritis Research & Therapy 2012, 14(Suppl 3):A63 (27 September 2012) |
|
Nonlymphoma hematological malignancies in systemic lupus erythematosus M Lu, R Ramsey-Goldman, S Bernatsky, M Petri, S Manzi, MB Urowitz, D Gladman, PR Fortin, E Ginzler, E Yelin, S-C Bae, DJ Wallace, S Jacobsen, MA Dooley, CA Peschken, GS Alarcón, O Nived, L Gottesman, L Criswell, G Sturfelt, L Dreyer, JL Lee, AE Clarke Arthritis Research & Therapy 2012, 14(Suppl 3):A64 (27 September 2012) |

